Similar articles for PMID: 29524758

Year	Number of Results
1965	2
1976	1
1982	1
1988	1
1992	1
1996	1
1999	2
2002	2
2004	1
2005	2
2006	5
2007	3
2008	4
2009	2
2010	5
2011	6
2012	6
2013	4
2014	8
2015	14
2016	14
2017	11
2018	14
2019	8
2020	8
2021	14
2022	10
2023	2
2024	0

1

A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review.

Shahmohammadi S, Sahraian MA, Shahmohammadi A, Doosti R, Zare-Mirzaie A, Naser Moghadasi A. Shahmohammadi S, et al. Mult Scler Relat Disord. 2018 May;22:22-26. doi: 10.1016/j.msard.2018.02.030. Epub 2018 Mar 1. Mult Scler Relat Disord. 2018. PMID: 29524758 Review.

2

De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report.

Sakamoto T, Sato Y, Yamamoto S, Oya H, Hatakeyama K. Sakamoto T, et al. Transplant Proc. 2012 Mar;44(2):570-3. doi: 10.1016/j.transproceed.2012.01.007. Transplant Proc. 2012. PMID: 22410071

3

Severe neutropenia after rituximab-treatment of multiple sclerosis.

Rissanen E, Remes K, Airas L. Rissanen E, et al. Mult Scler Relat Disord. 2018 Feb;20:3-5. doi: 10.1016/j.msard.2017.12.005. Epub 2017 Dec 12. Mult Scler Relat Disord. 2018. PMID: 29253744 Free article.

4

[Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis].

Midaglia L, Mora L, Mulero P, Sastre-Garriga J, Montalban X. Midaglia L, et al. Rev Neurol. 2018 Jan 1;66(1):25-32. Rev Neurol. 2018. PMID: 29251340 Free article. Review. Spanish.

5

Rituximab-induced serum sickness in multiple sclerosis patients.

Wolf AB, Ryerson LZ, Pandey K, McGettigan BM, Vollmer T, Corboy JR, Alvarez E. Wolf AB, et al. Mult Scler Relat Disord. 2019 Nov;36:101402. doi: 10.1016/j.msard.2019.101402. Epub 2019 Sep 17. Mult Scler Relat Disord. 2019. PMID: 31542710

6

Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.

Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D. Chatzinasiou F, et al. Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5. Acta Dermatovenerol Croat. 2016. PMID: 27149138

7

Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience.

D'Amico E, Zanghì A, Chisari CG, Fermo SL, Toscano S, Arena S, Patti F, Zappia M. D'Amico E, et al. Mult Scler Relat Disord. 2019 Jan;27:324-326. doi: 10.1016/j.msard.2018.09.041. Epub 2018 Oct 3. Mult Scler Relat Disord. 2019. PMID: 30471585

8

Hypocomplementemic urticarial vasculitis and multiple Sclerosis: A rare association or an atypical presentation?

Durães J, Gonçalo M, Sousa L, Macário MC. Durães J, et al. Mult Scler Relat Disord. 2019 May;30:244-246. doi: 10.1016/j.msard.2019.02.020. Epub 2019 Feb 15. Mult Scler Relat Disord. 2019. PMID: 30849680

9

Rituximab for refractory autoimmune hepatitis: a case report.

Al-Busafi SA, Michel RP, Deschenes M. Al-Busafi SA, et al. Arab J Gastroenterol. 2013 Sep;14(3):135-8. doi: 10.1016/j.ajg.2013.08.009. Epub 2013 Sep 27. Arab J Gastroenterol. 2013. PMID: 24206745

10

Successful treatment of refractory autoimmune hepatitis with rituximab.

D'Agostino D, Costaguta A, Álvarez F. D'Agostino D, et al. Pediatrics. 2013 Aug;132(2):e526-30. doi: 10.1542/peds.2011-1900. Epub 2013 Jul 1. Pediatrics. 2013. PMID: 23821693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

138 results

Results by year